Home Top News Millions of vaccines are in storage, and the White House does not yet want to release them

Millions of vaccines are in storage, and the White House does not yet want to release them


The Ohio plant has already produced about 30 million doses of the vaccine in ampoules, and the Maryland plant has produced enough to produce a few million more injections.

The goal is a typical Independence Day. Biden ordered widespread access to vaccines

The fate of these benefits is accordingly Now They are having a heated debate in the White House.

The use of the astrogenic vaccine has already been approved by more than seventy countries around the world, but the results of clinical trials are still awaited in the United States, and the company has not even applied to the local regulatory authority for conditional registration.

At the same time, NYT writes that some executives consider the government to allow the export of at least part of these highly sought-after benefits, while others are reluctant to give up such shares.

White House spokeswoman Jen Psaki said on Thursday that companies would not be able to meet the U.S. if they first meet the promised deliveries to the United States. He said the manufactured blocks could be exported.

AstraZenecy Beware and Competitive

These discussions include AstraZeneca, which has called on the administration of President Joe Biden to provide US benefits to the EU, where it has failed to meet its distribution obligations, which generally slows down the European vaccination campaign. However, the US government has so far denied it, an unnamed official told NYT.

AstraZeneca again reduced the vaccine supply. It will only offer one-third of the benefits by April

See also  Stay or leave: Biden considers leaving troops in Afghanistan

“We are aware that other governments have asked the United States to donate the Astrogenega (vaccine) dose, and we have asked the U.S. government to carefully consider these requirements,” said Gonzalo Vina, a spokeswoman for the pharmaceutical company.

The United States has provided significant financial assistance for the development of the astrogenesis vaccine in collaboration with the University of Oxford. Many experts speculate that it may be one of the first and relatively inexpensive vaccines approved for use in the United States.

However, according to the media, AstraZeneca made several mistakes in communicating with US regulators, which had to suspend its clinical trials for seven weeks last fall, and its results are still awaited.

Meanwhile, Biden has ordered the supply of additional products for the other three vaccines, which have already been given the green light by US authorities, namely Pfizer / Bioendech, Moderna and more recently Johnson & Johnson. According to the NYT, the astrogeneca vaccine is progressing slowly in the country, and the United States may eventually use it only partially.

The European Union has exported millions of vaccines. You are blaming Britain and the US and blocking them

Even so, they are still reluctant to give up their stuff. “If we have a surplus, we will share it with the rest of the world,” Biden said of U.S. vaccine stocks on Wednesday. “But let’s start by taking care of Americans first,” the president added, promising in a speech Friday night that all Americans over the age of 18 can register for a vaccination date of May 1st.

See also  One picture too many: Slovenia's presidency of the European Union begins with a scandal

Due to the persistent epidemic and lack of vaccines, diplomatic divisions between some states are escalating, blaming each other for “vaccine nationalism”. The EU faced such criticism when Italy blocked the export of EU-produced AstraZeneca to Australia last week, saying the company must first fulfill its commitment to the EU camp.

To defend the criticism, the European Union has accused the United States and the United Kingdom of blocking the export of vaccines, which the UK government has vehemently opposed.


Please enter your comment!
Please enter your name here